{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T22:31:13Z","timestamp":1772145073233,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J01407"],"award-info":[{"award-number":["2021J01407"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2020GGA020"],"award-info":[{"award-number":["2020GGA020"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The etiology of fetal growth restriction (FGR) is complex and currently, there is a paucity of research about the genetic etiology of fetal growth restriction. We investigated the genetic associations and pregnancy outcomes in cases of fetal growth restriction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of 210 pregnant women with fetal growth restriction was performed using karyotype analysis and single nucleotide polymorphism arrays (SNP-array). The differences in pathogenic copy number variation (CNV) detected by the two methods were compared. At the same time, the fetuses were divided into three groups: isolated FGR (n\u2009=\u2009117), FGR with ultrasonographic soft markers (n\u2009=\u200948), and FGR with ultrasonographic structural anomalies (n\u2009=\u200945). Further, the differences in pathogenic copy number variations were compared among the groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The total detection rate of pathogenic CNVs was 12.4% (26\/210). Pathogenic copy number variation was detected in 14 cases (6.7%, 14\/210) by karyotype analysis. Furthermore, 25 cases (11.9%, 25\/210) with pathogenic CNVs were detected using the SNP-array evaluation method. The difference in the pathogenic CNV detection rate between the two methods was statistically significant. The result of the karyotype analysis and SNP-array evaluation was inconsistent for 13 cases with pathogenic CNV. The rate of detecting pathogenic CNVs in fetuses with isolated FGR, FGR combined with ultrasonographic soft markers, and FGR combined with ultrasonographic structural malformations was 6.0, 10.4, and 31.1%, respectively, with significant differences among the groups. During the follow-up, 35 pregnancies were terminated, two abortions occurred, and 13 cases were lost to follow-up. Of the 160 deliveries, nine fetuses had adverse pregnancy outcomes, and the remaining 151 had normal postnatal growth and developmental assessments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Early diagnosis and timely genomic testing for fetal growth restriction can aid in its perinatal prognosis and subsequent intervention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03373-z","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T08:02:40Z","timestamp":1649491360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fetal growth restriction: associated genetic etiology and pregnancy outcomes in a tertiary referral center"],"prefix":"10.1186","volume":"20","author":[{"given":"Meiying","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianguo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangpu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"3373_CR1","doi-asserted-by":"crossref","unstructured":"ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2019; 121(5):1122-1133","DOI":"10.1097\/01.AOG.0000429658.85846.f9"},{"key":"3373_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00404-017-4341-9","volume":"295","author":"L Nardozza","year":"2017","unstructured":"Nardozza L, Caetano A, Zamarian A, Mazzola JB, J\u00fanior E. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295:1\u201317.","journal-title":"Arch Gynecol Obstet"},{"key":"3373_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000357592","volume":"30","author":"F Figueras","year":"2014","unstructured":"Figueras F, Gratac\u00f3s E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;30:86\u201398.","journal-title":"Fetal Diagn Ther"},{"key":"3373_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.12.003","author":"F Figueras","year":"2018","unstructured":"Figueras F, Caradeux J, Crispi F, Eixarch E, Peguero A, Gratacos E. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol. 2018. https:\/\/doi.org\/10.1016\/j.ajog.2017.12.003.","journal-title":"Am J Obstet Gynecol"},{"key":"3373_CR5","doi-asserted-by":"publisher","first-page":"743639","DOI":"10.3389\/fped.2021.743639","volume":"9","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xie Y, Jiang Y, Luo Q, Shi L, Zeng S, Zhuang J, Lyu G. The genetic etiology diagnosis of fetal growth restriction using single-nucleotide polymorphism-based chromosomal microarray analysis. Front Pediatr. 2021;9:743639.","journal-title":"Front Pediatr"},{"issue":"1","key":"3373_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/jcmm.16080","volume":"25","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhong M, Zheng D. Chromosomal mosaicism detected by karyotyping and chromosomal microarray analysis in prenatal diagnosis. J Cell Mol Med. 2021;25(1):358\u201366.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"3373_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/pd.2933","volume":"32","author":"PD Brady","year":"2012","unstructured":"Brady PD, Vermeesch JR. Genomic microarrays: a technology overview. Prenat Diagn. 2012;32(4):336\u201343.","journal-title":"Prenat Diagn"},{"issue":"4","key":"3373_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/uog.14745","volume":"45","author":"MI Srebniak","year":"2015","unstructured":"Srebniak MI, Opstal DV, Joosten M, Diderich K, Vries F, Riedijk S, et al. Whole-genome array as a first-line cytogenetic test in prenatal diagnosis. Ultrasound Obstet Gynecol. 2015;45(4):363\u201372.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"3373_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/GIM.0b013e3181f8baad","volume":"12","author":"M Melanie","year":"2010","unstructured":"Melanie M, Louanne H. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12(11):742\u20135.","journal-title":"Genet Med"},{"key":"3373_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5468\/ogs.2016.59.2.91","volume":"59","author":"HY Choi","year":"2016","unstructured":"Choi HY, Kim JH, Park JY, Jung EY, No JH, Oh KJ, Hong JS. Simple mathematical formulae for estimation of median values of fetal biometry at each gestational age. Obstet Gynecol Sci. 2016;59:91\u20136.","journal-title":"Obstet Gynecol Sci"},{"issue":"11","key":"3373_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/gim.2013.129","volume":"15","author":"ST South","year":"2013","unstructured":"South ST, Lee C, Lamb AN, Higgins AW, Kearney HM. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med. 2013;15(11):901\u20139.","journal-title":"Genet Med"},{"issue":"7","key":"3373_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/GIM.0b013e3182217a3a","volume":"13","author":"HM Kearney","year":"2011","unstructured":"Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680\u20135.","journal-title":"Genet Med"},{"issue":"4","key":"3373_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/AOG.0000000000003207","volume":"133","author":"A Jelin","year":"2019","unstructured":"Jelin A, Sagaser K, Lawson C, Forster KR, Blakemore K. Chromosomal microarray analysis results from pregnancies with various ultrasonographic anomalies. Obstet Gynecol. 2019;133(4):827\u20138.","journal-title":"Obstet Gynecol"},{"key":"3373_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/pd.4844","volume":"36","author":"H Zhu","year":"2016","unstructured":"Zhu H, Lin S, Huang L, He Z, Huang X, Zhou Y, Fang Q, Luo Y. Application of chromosomal microarray analysis in prenatal diagnosis of fetal growth restriction. Prenat Diagn. 2016;36:686.","journal-title":"Prenat Diagn"},{"issue":"9","key":"3373_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.gyobfe.2014.07.002","volume":"42","author":"S Vanlieferinghen","year":"2014","unstructured":"Vanlieferinghen S, Bernard JP, Salomon LJ, Chalouhi GE, Russell NE, Ville Y. Second trimester growth restriction and underlying fetal anomalies. Gynecol Obstet Fertil. 2014;42(9):567\u201371.","journal-title":"Gynecol Obstet Fertil"},{"key":"3373_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0002-9378(93)90491-Z","volume":"168","author":"RJ Snijders","year":"1993","unstructured":"Snijders RJ, Sherrod C, Gosden CM, Nicolaides KH. Fetal growth retardation: associated malformations and chromosomal abnormalities. Am J Obstet Gynec. 1993;168:547\u201355.","journal-title":"Am J Obstet Gynec"},{"issue":"2","key":"3373_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00003081-200606000-00006","volume":"49","author":"D Maulik","year":"2006","unstructured":"Maulik D. Fetal growth restriction: the etiology. Clin Obstet Gynecol. 2006;49(2):228\u201335.","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"3373_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00404-018-4798-1","volume":"298","author":"Y Xing","year":"2018","unstructured":"Xing Y, Holder JL, Liu Y, Sun L. Prenatal diagnosis of Wolf-Hirschhorn syndrome: from ultrasound findings, diagnostic technology to genetic counseling. Arch Gynecol Obstet. 2018;298(2):289\u201395.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"3373_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/pd.2861","volume":"32","author":"N Gruchy","year":"2012","unstructured":"Gruchy N, Decamp M, Richard N, Leporrier N. Array CGH analysis in high-risk pregnancies: comparing DNA from cultured cells and cell-free fetal DNA. Prenat Diagn. 2012;32(4):383\u20138.","journal-title":"Prenat Diagn"},{"issue":"7","key":"3373_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/uog.3884","volume":"28","author":"M Chen","year":"2006","unstructured":"Chen M, Hwu WL, Kuo SJ, Chen CP, Lin C-C. Subtelomeric rearrangements and 22q11.2 deletion syndrome in anomalous growth-restricted fetuses with normal or balanced G-banded karyotype. Ultrasound Obstet Gynecol. 2006;28(7):939\u201343.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3373_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejogrb.2018.03.047","volume":"225","author":"L Zhen","year":"2018","unstructured":"Zhen L, Fan SS, Huang LY, Pan M, Han J, Yang X, Li DZ. Prenatal diagnosis of Wolf-Hirschhorn syndrome: ultrasonography and molecular karyotyping results. Eur J Obstet Gynecol Reprod Biol. 2018;225:19\u201321.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"3373_CR22","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.1074\/jbc.M114.632786","volume":"290","author":"Y Guo","year":"2015","unstructured":"Guo Y, Scheuermann TH, Partch CL, Tomchick DR, Gardner KH. Coiled-coil coactivators play a structural role mediating interactions in hypoxia-inducible factor heterodimerization. J Biol Chem. 2015;290(12):7707\u201321.","journal-title":"J Biol Chem"},{"issue":"3","key":"3373_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.molcel.2007.04.011","volume":"26","author":"T Narita","year":"2007","unstructured":"Narita T, Yung TM, Yamamoto J, Tsuboi Y, Tanabe H, Tanaka K, Yamaguchi Y, Handa H. NELF interacts with CBC and participates in 3\u2019 end processing of replication-dependent histone mRNAs. Mol Cell. 2007;26(3):349\u201365.","journal-title":"Mol Cell"},{"issue":"4","key":"3373_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00125-013-2832-1","volume":"56","author":"LE Docherty","year":"2013","unstructured":"Docherty LE, Kabwama L, Hawke H, Flanagan SE, Ellard H. Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients. Diabetologia. 2013;56(4):758\u201362.","journal-title":"Diabetologia"},{"key":"3373_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1566523220666200424085336","volume":"20","author":"Z Mian-Ling","year":"2020","unstructured":"Mian-Ling Z, Yun-Qi C, Chao-Chun Z. Prader-willi syndrome: molecular mechanism and epigenetic therapy. Curr Gene Ther. 2020;20:36\u201343.","journal-title":"Curr Gene Ther"},{"key":"3373_CR26","doi-asserted-by":"publisher","first-page":"633532","DOI":"10.3389\/fped.2021.633532","volume":"9","author":"Y Hu","year":"2021","unstructured":"Hu Y, Xue XD, Fu JH. Case report: clinical analysis of seven neonates with prader-willi syndrome and review of the literature. Front Pediatr. 2021;9:633532.","journal-title":"Front Pediatr"},{"issue":"3","key":"3373_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/cge.12064","volume":"84","author":"H Carmichael","year":"2013","unstructured":"Carmichael H, Shen Y, Nguyen T, Hirschhorn J, Dauber A. Whole exome sequencing in a patient with uniparental disomy of chromosome 2 and a complex phenotype. Clin Genet. 2013;84(3):213\u201322.","journal-title":"Clin Genet"},{"key":"3373_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13039-018-0382-4","volume":"11","author":"G An","year":"2018","unstructured":"An G, Lin Y, Xu LP, Yang F. Application of chromosomal microarray to investigate genetic causes of isolated fetal growth restriction. Mol Cytogenet. 2018;11:33\u20139.","journal-title":"Mol Cytogenet"},{"issue":"1","key":"3373_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000479506","volume":"44","author":"A Borrell","year":"2018","unstructured":"Borrell A, Grande M, Pauta M, Figueras F. Chromosomal microarray analysis in fetuses with growth restriction and normal karyotype: a systematic review and meta-analysis. Fetal Diagn Ther. 2018;44(1):1\u20139.","journal-title":"Fetal Diagn Ther"},{"issue":"23","key":"3373_CR30","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","volume":"367","author":"RJ Wapner","year":"2012","unstructured":"Wapner RJ, Martin CL, Levy B, Jackson L. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175\u201384.","journal-title":"N Engl J Med"},{"key":"3373_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-4939-8889-1_13","volume":"1885","author":"M Ganapathi","year":"2019","unstructured":"Ganapathi M, Nahum O, Levy B. Prenatal diagnosis using chromosomal SNP microarrays. Methods Mol Biol. 2019;1885:187\u2013205.","journal-title":"Methods Mol Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03373-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03373-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03373-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T08:07:50Z","timestamp":1649491670000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03373-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3373"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03373-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fujian Maternal and Child Health Hospital (Approval No. 2014042). All procedures were applied following the Declaration of Helsinki, as well as international and national laws, guidelines and regulations. Signed informed consent was obtained from all the pregnant women enrolled in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}